| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
809,661 |
744,476 |
$65.18M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
919,464 |
836,730 |
$54.13M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
47,667 |
45,935 |
$6.11M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
216,337 |
209,491 |
$5.77M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
51,110 |
50,429 |
$4.95M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
110,385 |
104,828 |
$4.74M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
46,099 |
45,400 |
$4.46M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
25,657 |
24,366 |
$4.06M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43,330 |
41,837 |
$3.74M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
34,757 |
34,234 |
$3.65M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
31,753 |
30,844 |
$2.80M |
| L3000 |
Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each |
12,470 |
5,908 |
$2.60M |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24,340 |
23,689 |
$2.48M |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
22,536 |
22,036 |
$2.41M |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
224,152 |
215,000 |
$2.40M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64,999 |
61,461 |
$2.38M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
8,517 |
8,171 |
$2.37M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
3,845 |
3,778 |
$2.15M |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
12,848 |
12,713 |
$2.12M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
6,699 |
6,208 |
$2.04M |
| 92552 |
|
59,990 |
59,185 |
$1.73M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
123,096 |
77,176 |
$1.65M |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
6,391 |
5,783 |
$1.63M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
5,060 |
4,661 |
$1.46M |
| 93970 |
|
8,805 |
8,472 |
$1.30M |
| 90461 |
|
55,435 |
53,882 |
$1.23M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
35,827 |
13,364 |
$1.04M |
| 90832 |
Psychotherapy, 30 minutes with patient |
16,121 |
11,650 |
$953K |
| 99243 |
|
8,239 |
8,231 |
$905K |
| 99215 |
Prolong outpt/office vis |
9,268 |
8,677 |
$872K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
62,582 |
59,883 |
$840K |
| 93000 |
|
69,847 |
67,045 |
$837K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
16,920 |
15,250 |
$830K |
| 36465 |
|
705 |
441 |
$799K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
88,666 |
76,545 |
$772K |
| 93229 |
|
1,517 |
1,303 |
$747K |
| 27447 |
|
989 |
893 |
$629K |
| 93015 |
|
9,322 |
8,999 |
$623K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,739 |
1,475 |
$596K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
5,616 |
5,352 |
$588K |
| 20610 |
|
10,870 |
8,402 |
$554K |
| 95806 |
|
3,761 |
3,663 |
$516K |
| 73620 |
|
25,083 |
14,997 |
$496K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25,943 |
22,477 |
$484K |
| 92588 |
|
18,558 |
18,297 |
$467K |
| 36475 |
|
294 |
229 |
$430K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,907 |
7,366 |
$426K |
| 93880 |
|
3,009 |
2,817 |
$420K |
| 93925 |
|
2,683 |
2,556 |
$419K |
| 95782 |
|
438 |
392 |
$418K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
1,349 |
747 |
$418K |
| 31231 |
|
2,254 |
2,141 |
$418K |
| 95811 |
|
797 |
768 |
$390K |
| 29540 |
|
17,762 |
10,489 |
$378K |
| 96127 |
|
72,642 |
70,326 |
$330K |
| 90686 |
|
42,095 |
39,364 |
$306K |
| 98941 |
Chiropractic manipulative treatment; spinal, 3-4 regions |
9,944 |
3,966 |
$302K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
4,635 |
4,074 |
$271K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
9,840 |
9,081 |
$265K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
2,302 |
1,276 |
$247K |
| 90834 |
Psychotherapy, 45 minutes with patient |
2,769 |
2,377 |
$226K |
| 90674 |
|
15,321 |
14,466 |
$223K |
| 90746 |
|
4,361 |
4,152 |
$217K |
| 92250 |
|
5,713 |
5,210 |
$213K |
| 94060 |
|
4,578 |
4,331 |
$212K |
| 94729 |
|
4,853 |
4,607 |
$209K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,873 |
3,435 |
$206K |
| 99188 |
|
12,370 |
11,997 |
$202K |
| 73564 |
|
4,937 |
4,042 |
$195K |
| 92551 |
|
25,778 |
25,347 |
$189K |
| 17110 |
|
2,360 |
1,959 |
$189K |
| 93971 |
|
1,821 |
1,466 |
$187K |
| 90791 |
Psychiatric diagnostic evaluation |
1,354 |
1,311 |
$184K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
761 |
732 |
$180K |
| 90651 |
|
5,933 |
5,022 |
$180K |
| 31575 |
|
1,880 |
1,813 |
$174K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
3,687 |
3,558 |
$173K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
3,719 |
3,211 |
$172K |
| 95930 |
|
1,728 |
1,727 |
$171K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,236 |
4,104 |
$162K |
| 95117 |
|
16,871 |
10,091 |
$162K |
| 94727 |
|
4,855 |
4,614 |
$160K |
| 97161 |
|
3,606 |
3,518 |
$150K |
| 99205 |
Prolong outpt/office vis |
918 |
889 |
$150K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,380 |
2,357 |
$138K |
| 99385 |
|
1,223 |
1,199 |
$137K |
| 93268 |
|
625 |
625 |
$135K |
| 99460 |
|
1,871 |
1,833 |
$133K |
| 99174 |
|
15,408 |
15,066 |
$127K |
| 69210 |
|
3,917 |
3,359 |
$126K |
| 99233 |
Prolong inpt eval add15 m |
2,999 |
1,462 |
$113K |
| 36466 |
|
78 |
64 |
$113K |
| 11900 |
|
2,877 |
2,577 |
$111K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,417 |
8,083 |
$110K |
| 92567 |
|
8,550 |
8,091 |
$105K |
| 99223 |
Prolong inpt eval add15 m |
1,515 |
1,401 |
$104K |
| 90670 |
|
9,386 |
8,568 |
$104K |
| 11901 |
|
2,037 |
1,861 |
$98K |
| 90715 |
|
4,012 |
3,666 |
$97K |
| 93923 |
|
1,552 |
1,522 |
$96K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,328 |
4,936 |
$87K |
| 92557 |
|
3,687 |
3,559 |
$87K |
| 20611 |
|
1,307 |
957 |
$85K |
| 73630 |
|
3,555 |
2,689 |
$80K |
| 99245 |
|
418 |
418 |
$79K |
| 94010 |
|
2,970 |
2,879 |
$78K |
| 99386 |
|
599 |
589 |
$78K |
| 90750 |
|
616 |
570 |
$72K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
3,245 |
1,043 |
$70K |
| 0012A |
|
2,491 |
2,490 |
$69K |
| 64483 |
|
430 |
426 |
$69K |
| 73562 |
|
2,150 |
1,856 |
$66K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,661 |
2,541 |
$63K |
| 73030 |
|
2,111 |
1,823 |
$63K |
| 90619 |
|
2,311 |
2,189 |
$61K |
| 92225 |
|
1,394 |
1,363 |
$61K |
| 83655 |
|
6,091 |
5,920 |
$58K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15,936 |
12,789 |
$57K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,756 |
1,490 |
$57K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
15,585 |
14,002 |
$54K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,624 |
1,251 |
$53K |
| 99173 |
|
50,914 |
45,509 |
$51K |
| 92550 |
|
4,102 |
3,932 |
$51K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,987 |
1,232 |
$48K |
| 0011A |
|
2,704 |
2,696 |
$48K |
| 0071A |
|
1,194 |
1,184 |
$46K |
| 10060 |
|
505 |
443 |
$44K |
| 98940 |
|
1,850 |
794 |
$41K |
| 92136 |
|
912 |
805 |
$40K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,308 |
1,826 |
$39K |
| 94618 |
|
1,434 |
1,340 |
$38K |
| 95012 |
|
2,199 |
2,099 |
$37K |
| 11301 |
|
355 |
330 |
$37K |
| 10061 |
|
257 |
236 |
$36K |
| 99442 |
|
1,113 |
1,044 |
$36K |
| 11306 |
|
247 |
215 |
$35K |
| 92579 |
|
966 |
951 |
$35K |
| 96401 |
|
543 |
429 |
$34K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,126 |
2,930 |
$34K |
| 90621 |
|
1,347 |
1,305 |
$34K |
| 72100 |
|
1,165 |
1,093 |
$33K |
| 99443 |
|
973 |
735 |
$33K |
| 0072A |
|
828 |
827 |
$33K |
| 73600 |
|
1,481 |
1,096 |
$32K |
| 99441 |
|
1,755 |
1,553 |
$31K |
| 72114 |
|
445 |
441 |
$31K |
| 99397 |
|
749 |
677 |
$31K |
| 97164 |
|
1,093 |
1,042 |
$28K |
| 36416 |
|
6,201 |
5,263 |
$28K |
| 90734 |
|
1,606 |
1,583 |
$28K |
| 99462 |
|
861 |
666 |
$28K |
| 90682 |
|
627 |
627 |
$28K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,222 |
2,155 |
$28K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
239 |
201 |
$27K |
| 94664 |
|
2,573 |
2,425 |
$27K |
| 92587 |
|
1,572 |
1,514 |
$27K |
| 90677 |
|
2,557 |
2,486 |
$27K |
| 93228 |
|
1,476 |
1,274 |
$25K |
| 73610 |
|
1,011 |
805 |
$25K |
| 93458 |
|
114 |
111 |
$25K |
| 86580 |
|
3,709 |
3,682 |
$25K |
| 72110 |
|
475 |
475 |
$24K |
| 29515 |
|
426 |
228 |
$24K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,307 |
1,266 |
$24K |
| 93298 |
|
1,430 |
1,366 |
$23K |
| 73521 |
|
622 |
581 |
$22K |
| 76857 |
|
770 |
732 |
$22K |
| 94375 |
|
648 |
615 |
$21K |
| 93922 |
|
289 |
251 |
$21K |
| 11721 |
|
2,188 |
2,085 |
$21K |
| 96112 |
|
232 |
214 |
$20K |
| 99401 |
|
1,916 |
1,878 |
$20K |
| 0064A |
|
636 |
614 |
$20K |
| 99220 |
|
254 |
254 |
$19K |
| 62323 |
|
167 |
160 |
$19K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
383 |
337 |
$18K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,653 |
1,474 |
$17K |
| 90698 |
|
5,309 |
4,913 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,641 |
3,660 |
$16K |
| 76775 |
|
361 |
345 |
$16K |
| 93296 |
|
1,499 |
1,374 |
$16K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
22 |
12 |
$15K |
| 72275 |
|
535 |
527 |
$15K |
| 66761 |
|
80 |
49 |
$15K |
| 92134 |
|
657 |
593 |
$15K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
455 |
155 |
$14K |
| 92558 |
|
1,777 |
1,719 |
$14K |
| 96101 |
|
263 |
249 |
$14K |
| 64493 |
|
138 |
130 |
$14K |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
83 |
74 |
$13K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
72 |
72 |
$13K |
| 99348 |
|
685 |
585 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
188 |
78 |
$12K |
| 73560 |
|
454 |
424 |
$12K |
| 11750 |
|
85 |
81 |
$12K |
| 90662 |
|
1,988 |
1,873 |
$12K |
| 98942 |
|
260 |
98 |
$12K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
721 |
586 |
$12K |
| 85018 |
|
5,768 |
5,572 |
$11K |
| 93297 |
|
788 |
728 |
$11K |
| 0001A |
|
395 |
392 |
$10K |
| 90633 |
|
4,406 |
3,923 |
$10K |
| 0002A |
|
283 |
283 |
$10K |
| 11102 |
|
131 |
124 |
$9K |
| J2785 |
Injection, regadenoson, 0.1 mg |
383 |
352 |
$9K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,087 |
2,731 |
$9K |
| 20605 |
|
266 |
247 |
$9K |
| 93294 |
|
823 |
755 |
$9K |
| 92025 |
|
348 |
326 |
$8K |
| 90836 |
|
143 |
133 |
$8K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
3,197 |
2,714 |
$8K |
| 57454 |
|
62 |
61 |
$8K |
| 95115 |
|
930 |
562 |
$8K |
| 90756 |
|
469 |
449 |
$8K |
| 90661 |
|
3,330 |
3,305 |
$7K |
| 93295 |
|
323 |
292 |
$7K |
| 90620 |
|
150 |
147 |
$7K |
| 90680 |
|
3,468 |
3,239 |
$7K |
| 0013A |
|
249 |
241 |
$7K |
| 90710 |
|
406 |
341 |
$7K |
| L3260 |
Surgical boot/shoe, each |
302 |
283 |
$7K |
| 81025 |
|
1,295 |
1,044 |
$7K |
| 73502 |
|
167 |
161 |
$7K |
| 72050 |
|
122 |
122 |
$6K |
| 64494 |
|
136 |
128 |
$6K |
| 95805 |
|
14 |
14 |
$6K |
| 95018 |
|
54 |
52 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
513 |
482 |
$6K |
| 92083 |
|
141 |
125 |
$6K |
| 92015 |
Determination of refractive state |
5,420 |
4,622 |
$6K |
| 99381 |
|
70 |
67 |
$6K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
998 |
911 |
$6K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,474 |
1,261 |
$6K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,038 |
915 |
$6K |
| 57456 |
|
54 |
52 |
$6K |
| 92202 |
|
485 |
448 |
$5K |
| 64484 |
|
104 |
101 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,778 |
2,477 |
$5K |
| 72040 |
|
142 |
138 |
$5K |
| 92020 |
|
258 |
246 |
$5K |
| 20985 |
|
134 |
89 |
$5K |
| 99307 |
|
350 |
281 |
$5K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,115 |
947 |
$5K |
| 20550 |
|
112 |
83 |
$5K |
| 64495 |
|
90 |
86 |
$5K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
61 |
34 |
$5K |
| 11730 |
|
59 |
55 |
$4K |
| 90716 |
|
652 |
555 |
$4K |
| 97014 |
|
350 |
140 |
$4K |
| 11311 |
|
46 |
43 |
$4K |
| 99349 |
|
172 |
158 |
$4K |
| 90707 |
|
722 |
617 |
$4K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
27 |
14 |
$4K |
| 72052 |
|
71 |
71 |
$4K |
| 77002 |
|
82 |
70 |
$4K |
| 99336 |
|
543 |
385 |
$4K |
| 68761 |
|
26 |
25 |
$4K |
| 82962 |
|
6,878 |
5,745 |
$4K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
341 |
305 |
$4K |
| 95250 |
|
57 |
56 |
$4K |
| 73110 |
|
79 |
73 |
$4K |
| 81002 |
|
2,942 |
2,857 |
$3K |
| 97802 |
|
468 |
450 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
684 |
680 |
$3K |
| 90736 |
|
20 |
20 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
273 |
240 |
$3K |
| 99337 |
|
121 |
109 |
$3K |
| 87070 |
|
526 |
488 |
$3K |
| 99152 |
|
108 |
97 |
$3K |
| 94760 |
|
3,256 |
2,986 |
$3K |
| 73140 |
|
66 |
57 |
$3K |
| 99241 |
|
56 |
56 |
$3K |
| 93280 |
|
142 |
129 |
$3K |
| 81003 |
|
10,223 |
9,709 |
$3K |
| 92226 |
|
160 |
157 |
$3K |
| 90732 |
|
30 |
30 |
$3K |
| 90636 |
|
26 |
26 |
$2K |
| 51798 |
|
149 |
148 |
$2K |
| 90473 |
|
190 |
190 |
$2K |
| 87634 |
|
209 |
200 |
$2K |
| 99217 |
|
81 |
81 |
$2K |
| 99242 |
|
28 |
28 |
$2K |
| 90696 |
|
426 |
354 |
$2K |
| 95251 |
|
106 |
95 |
$2K |
| 92553 |
|
59 |
54 |
$2K |
| 92286 |
|
126 |
107 |
$2K |
| 90744 |
|
2,140 |
1,949 |
$2K |
| 90700 |
|
976 |
873 |
$2K |
| 87081 |
|
479 |
474 |
$2K |
| 76512 |
|
51 |
42 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,250 |
912 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,033 |
991 |
$2K |
| 80061 |
Lipid panel |
203 |
203 |
$2K |
| 97162 |
|
27 |
27 |
$2K |
| 33016 |
|
16 |
14 |
$2K |
| 60100 |
|
12 |
12 |
$2K |
| 0134A |
|
67 |
64 |
$1K |
| 00813 |
|
13 |
12 |
$1K |
| 69209 |
|
113 |
100 |
$1K |
| 92133 |
|
44 |
44 |
$1K |
| 99253 |
|
15 |
13 |
$1K |
| 29580 |
|
25 |
14 |
$1K |
| 10040 |
|
19 |
15 |
$1K |
| 76514 |
|
107 |
107 |
$1K |
| 90713 |
|
479 |
421 |
$1K |
| 91322 |
|
20 |
17 |
$1K |
| 36470 |
|
16 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
33 |
33 |
$1K |
| 93224 |
|
15 |
15 |
$1K |
| 90653 |
|
139 |
135 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
106 |
105 |
$995.17 |
| 90694 |
|
137 |
131 |
$893.48 |
| 00811 |
|
16 |
15 |
$883.50 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
169 |
142 |
$858.12 |
| 51741 |
|
92 |
91 |
$836.03 |
| 92201 |
|
44 |
44 |
$827.97 |
| 90632 |
|
13 |
13 |
$817.65 |
| 99383 |
|
12 |
12 |
$815.69 |
| 99051 |
|
1,590 |
1,546 |
$813.73 |
| G0008 |
Administration of influenza virus vaccine |
1,295 |
1,238 |
$810.91 |
| 91320 |
|
13 |
13 |
$807.75 |
| 36410 |
|
48 |
48 |
$791.02 |
| 87400 |
|
254 |
119 |
$760.12 |
| 90672 |
|
211 |
211 |
$758.42 |
| 73130 |
|
22 |
15 |
$733.88 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
23 |
19 |
$662.08 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
13 |
$658.38 |
| 90480 |
|
33 |
31 |
$657.80 |
| 94770 |
|
334 |
332 |
$656.66 |
| 96161 |
|
250 |
230 |
$655.52 |
| 90697 |
|
297 |
294 |
$605.40 |
| 99406 |
|
69 |
54 |
$600.51 |
| 99497 |
|
45 |
35 |
$578.40 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
88 |
84 |
$555.00 |
| 11056 |
|
61 |
57 |
$544.19 |
| 90649 |
|
120 |
75 |
$530.57 |
| 91301 |
|
4,610 |
4,529 |
$528.00 |
| 90688 |
|
144 |
109 |
$519.32 |
| 97803 |
|
211 |
202 |
$509.82 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
241 |
239 |
$504.65 |
| 97022 |
|
176 |
69 |
$498.26 |
| 73080 |
|
13 |
13 |
$495.59 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,057 |
840 |
$482.12 |
| 99335 |
|
104 |
71 |
$478.38 |
| 94070 |
|
14 |
13 |
$473.68 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
68 |
65 |
$471.86 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,625 |
515 |
$466.09 |
| 93016 |
|
28 |
24 |
$399.56 |
| 99459 |
|
22 |
21 |
$391.45 |
| 3074F |
|
19,193 |
17,810 |
$382.00 |
| 3078F |
|
17,642 |
16,362 |
$375.00 |
| 90648 |
|
523 |
470 |
$357.64 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
116 |
116 |
$343.24 |
| 97035 |
|
170 |
58 |
$321.44 |
| 97032 |
|
115 |
42 |
$278.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
419 |
380 |
$271.77 |
| 99225 |
|
14 |
12 |
$268.78 |
| 96160 |
|
93 |
93 |
$234.64 |
| 90656 |
|
1,160 |
1,149 |
$234.37 |
| 93018 |
|
28 |
24 |
$226.23 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
140 |
123 |
$214.11 |
| 99024 |
|
3,802 |
3,192 |
$213.00 |
| 90658 |
|
47 |
45 |
$186.40 |
| 92132 |
|
12 |
12 |
$178.00 |
| 11720 |
|
27 |
26 |
$177.91 |
| 99347 |
|
13 |
13 |
$163.45 |
| 90685 |
|
206 |
203 |
$154.70 |
| 3079F |
|
6,095 |
5,728 |
$151.00 |
| 90474 |
|
12 |
12 |
$148.18 |
| 85610 |
|
57 |
38 |
$143.03 |
| 87807 |
|
39 |
39 |
$119.88 |
| 76937 |
|
16 |
12 |
$110.11 |
| 99050 |
|
15 |
14 |
$84.85 |
| 3075F |
|
2,094 |
2,007 |
$75.00 |
| J7510 |
Prednisolone oral, per 5 mg |
29 |
28 |
$73.78 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
12 |
12 |
$72.34 |
| 82947 |
|
31 |
30 |
$64.55 |
| 96380 |
|
48 |
48 |
$61.28 |
| V2020 |
Frames, purchases |
6,286 |
6,118 |
$60.00 |
| 3077F |
|
2,311 |
2,174 |
$57.00 |
| 99072 |
|
3,009 |
2,681 |
$44.00 |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
6,024 |
3,114 |
$42.00 |
| 97760 |
|
30 |
28 |
$41.91 |
| G9016 |
Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only] |
14 |
13 |
$36.00 |
| 1126F |
|
425 |
399 |
$31.00 |
| 91307 |
|
90 |
86 |
$30.00 |
| 3045F |
|
136 |
110 |
$27.00 |
| 3061F |
|
252 |
227 |
$24.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,175 |
3,034 |
$21.00 |
| 3044F |
|
3,815 |
3,179 |
$20.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
20 |
13 |
$16.76 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
25,261 |
24,072 |
$15.20 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$11.00 |
| 1125F |
|
257 |
240 |
$10.00 |
| 3080F |
|
696 |
669 |
$9.00 |
| 3008F |
|
12,959 |
12,451 |
$7.00 |
| J2357 |
Injection, omalizumab, 5 mg |
31 |
24 |
$6.00 |
| 91300 |
|
103 |
103 |
$5.00 |
| 91313 |
|
61 |
56 |
$5.00 |
| 91306 |
|
27 |
27 |
$2.00 |
| 2024F |
|
14 |
14 |
$1.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
6,882 |
6,148 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
14,319 |
12,507 |
$0.00 |
| 0502F |
|
698 |
433 |
$0.00 |
| 4004F |
|
292 |
264 |
$0.00 |
| 1124F |
|
4,775 |
4,620 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
2,769 |
2,730 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,229 |
1,140 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
2,516 |
2,407 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,133 |
1,040 |
$0.00 |
| 1160F |
|
43 |
39 |
$0.00 |
| 1033F |
|
156 |
154 |
$0.00 |
| 94799 |
|
64 |
64 |
$0.00 |
| V2203 |
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
616 |
318 |
$0.00 |
| 1159F |
|
267 |
252 |
$0.00 |
| 2022F |
|
324 |
260 |
$0.00 |
| V2750 |
Anti-reflective coating, per lens |
2,695 |
1,367 |
$0.00 |
| 2028F |
|
27 |
27 |
$0.00 |
| 4040F |
|
17 |
16 |
$0.00 |
| 90655 |
|
29 |
29 |
$0.00 |
| J0897 |
Injection, denosumab, 1 mg |
44 |
29 |
$0.00 |
| 3288F |
|
45 |
27 |
$0.00 |
| 90630 |
|
12 |
12 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
1,858 |
1,718 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
19,696 |
17,047 |
$0.00 |
| 99000 |
|
812 |
763 |
$0.00 |
| 1036F |
|
10,294 |
9,612 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
26 |
26 |
$0.00 |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
2,610 |
1,341 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
389 |
288 |
$0.00 |
| J3590 |
Unclassified biologics |
347 |
239 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
256 |
251 |
$0.00 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
5,102 |
2,614 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
503 |
464 |
$0.00 |
| 92310 |
|
12 |
12 |
$0.00 |
| V2781 |
Progressive lens, per lens |
135 |
65 |
$0.00 |
| 1111F |
|
39 |
38 |
$0.00 |
| 1101F |
|
90 |
90 |
$0.00 |
| V2200 |
Sphere, bifocal, plano to plus or minus 4.00d, per lens |
199 |
98 |
$0.00 |
| V2299 |
Specialty bifocal (by report) |
110 |
53 |
$0.00 |
| S0620 |
Routine ophthalmological examination including refraction; new patient |
304 |
304 |
$0.00 |
| 2000F |
|
32 |
30 |
$0.00 |
| G8856 |
Referral to a physician for an otologic evaluation performed |
14 |
14 |
$0.00 |
| 0503F |
|
26 |
25 |
$0.00 |
| V2104 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens |
104 |
52 |
$0.00 |
| V2744 |
Tint, photochromatic, per lens |
142 |
69 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
36 |
31 |
$0.00 |
| 90673 |
|
13 |
12 |
$0.00 |